novel therapies for head and neck cancers: bispecific antibodies and fusion proteins
Published 1 month ago • 51 plays • Length 3:47Download video MP4
Download video MP3
Similar videos
-
2:19
elucidating novel biomarkers for head and neck cancers
-
3:12
novel immunotherapy approaches in metastatic head and neck cancer
-
1:25:50
head & neck cancers cme series: "immunotherapy and novel treatment options for head & neck cancers"
-
3:35
is there a use for anti-pdl-1 antibodies in recurrent head and neck cancer?
-
2:14
innovative approaches to the treatment of head and neck cancer
-
3:13
pd-l1 and alternative biomarkers in head and neck cancer
-
2:02
bispecific antibodies for b-cell lymphoma treatment | oncotarget
-
1:05
revisiting farnesyltransferase inhibitors for head and neck cancer
-
13:52
antibody based cancer therapies - creative biolabs
-
1:13
opportunities for novel targets or therapies in tnbc
-
1:56
bfcr4350a: a novel bispecific antibody in r/r myeloma therapy
-
3:56
treatment ovarian cancer with novel targeted therapies and io
-
3:17
the development of immunotherapies in the treatment of relapsed metastatic head and neck cancer
-
55:05
novel targeted therapy for low-grade lymphoid malignancies in older adults by dr. krem
-
2:10
novel therapies for the treatment of nsclc: immunotherapy and targeted agents
-
1:06
current and future treatment options for uveal melanoma
-
1:26
novel treatment strategies for braf v600e-mutant nsclc
-
1:56
eftilagimod alpha and pembrolizumab in patients with squamous head and neck carcinoma
-
28:40
bispecific antibody therapy in multiple myeloma